Bibliometric analysis of chloride channel research (2004–2019)

References

• Toro L, Li M, Zhang Z, et al. MaxiK channel and cell signalling. Pflugers Arch. 2014;466(5):875–886.
   PubMed Web of Science ®Google Scholar
• Ponnalagu D, Singh H. Anion channels of mitochondria. Handb Exp Pharmacol. 2017;240:71-101.
   PubMedGoogle Scholar
• Rao SG, Ponnalagu D, Patel NJ, et al. Three decades of chloride intracellular channel proteins: from organelle to organ physiology. Curr Protoc Pharmacol. 2018;80: 11.21.1–11.21.17.
   Google Scholar
• Crottès D, Jan LY. The multifaceted role of TMEM16A in cancer. Cell Calcium. 2019;82:102050.
   PubMed Web of Science ®Google Scholar
• Rao SG, Patel NJ, Singh H. Intracellular chloride channels: novel biomarkers in diseases[J]. Front Physiol. 2020;11:96.
   PubMed Web of Science ®Google Scholar
• Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014). Expert Opin Biol Ther. 2014;14(9):1295–1317.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang Z, Yang Y, et al. A bibliometric analysis of research on the risk of engineering nanomaterials during 1999–2012. SciTotal Environ. 2014;473:483–489.
   Google Scholar
• Lu C, Bing Z, Bi Z, et al. Top-100 most cited publications concerning network pharmacology: a bibliometric analysis. Evid Based Complement Alternat Med. 2019;2019:1–7.
   Web of Science ®Google Scholar
• Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Nat Acad Sci. 2004;101(suppl 1):5303–5310.
   PubMed Web of Science ®Google Scholar
• Nees Jan van E, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538.
   PubMed Web of Science ®Google Scholar
• Zhao D, Li J, Seehus C, et al. Bibliometric analysis of recent sodium channel research. Channels. 2018;12(1):311–325.
   PubMed Web of Science ®Google Scholar
• Liang YD, Li Y, Zhao J, et al. Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res. 2017;10:951.
   PubMed Web of Science ®Google Scholar
• Ousingsawat J, Martins JR, Schreiber R, et al. Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport. J Chem Biol. 2009;284(42):28698–28703.
   PubMed Web of Science ®Google Scholar
• Duvvuri U, Shiwarski DJ, Xiao D, et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012;72(13):3270–3281.
   PubMed Web of Science ®Google Scholar
• Birket SE, Davis JM, Fernandez CM, et al. Development of an airway mucus defect in the cystic fibrosis rat. Jci Insight. 2018;3(1). DOI:10.1172/jci.insight.97199
   PubMed Web of Science ®Google Scholar
• Heijerman HGM, McKone EF, Downey DG, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomized, phase 3 trial. Lancet. 2019;394(10212):1940–1948.
   PubMed Web of Science ®Google Scholar
• Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science. 2008;322(5901):590–594.
   PubMed Web of Science ®Google Scholar
• Yang YD, Cho H, Koo JY, et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature. 2008;455(7217):1210–1215.
   PubMed Web of Science ®Google Scholar
• Schroeder BC, Cheng T, Jan YN, et al. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell. 2008;134(6):1019–1029.
   PubMed Web of Science ®Google Scholar
• Ma T, Thiagarajah JR, Yang H, et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest. 2002;110(11):1651–1658.
   PubMed Web of Science ®Google Scholar
• Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A. 2009;106(44):18825–18830.
   PubMed Web of Science ®Google Scholar
• Van Goor F, Hadida S, Grootenhuis PD, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A. 2011;108(46):18843–18848.
   PubMed Web of Science ®Google Scholar
• Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365(18):1663–1672.
   PubMed Web of Science ®Google Scholar
• Wainwright CE, Elborn JS, Ramsey BW, et al. Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR. N Engl J Med. 2015;373(3):220–231.
   PubMed Web of Science ®Google Scholar
• Jentsch TJ, Stein V, Weinreich F, et al. Molecular structure and physiological function of chloride channels. Physiol Rev. 2002;82(2):503–568.
   PubMed Web of Science ®Google Scholar
• Dutzler R, Campbell EB, Cadene M, et al. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature. 2002;415(6869):287–294.
   PubMed Web of Science ®Google Scholar
• Shi J, Shi S, Shi S, et al. Bibliometric analysis of potassium channel research[J]. Channels (Austin). 2020;14(1):18–27.
   PubMed Web of Science ®Google Scholar
• Koivula FNM, McClenaghan NH, Harper AGS, et al. Islet-intrinsic effects of CFTR mutation. Diabetologia. 2016;59(7):1350–1355.
   PubMed Web of Science ®Google Scholar
• Taylor-Cousar JL. CFTR modulators: impact on fertility, pregnancy,and lactation in women with cystic fibrosis. J Clin Med. 2020;9(9):2706.
   Web of Science ®Google Scholar
• Savant AP, McColley SA. Cystic fibrosis year in review 2019: section 1 CFTR modulators. Pediatr Pulmonol. 2020:1–7.
   Web of Science ®Google Scholar
• Oh U, Jung J. Cellular functions of TMEM16/anoctamin. Pfluegers Archiv Eur J Physiol. 2016;468(3):443–453.
   PubMed Web of Science ®Google Scholar
• Ma K, Wang H, Yu J, et al. New insights on the regulation of Ca2+ -activated chloride channel TMEM16A. J Cell Physiol. 2017;232(4):707–716.
   PubMed Web of Science ®Google Scholar
• Danahay HL, Lilley S, Fox R, et al. TMEM16A potentiation: a novel therapeutic approach for the treatment of cystic fibrosis. Am J Respir Crit Care Med. 2020;201(8):946–954.
   PubMed Web of Science ®Google Scholar
• Zhou X, Zhao G. Global liposome research in the period of 1995–2014: a bibliometric analysis. Scientometrics. 2015;105(1):231–248.
   Web of Science ®Google Scholar
• Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–1073.
   PubMed Web of Science ®Google Scholar
• Ivanov M, Matsvay A, Glazova O, et al. Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis. BMC Med Genomics. 2018;11(S1):13.
   PubMedGoogle Scholar
• Accurso FJ, Rowe SM, Clancy JP, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363(21):1991–2003.
   PubMed Web of Science ®Google Scholar
• Christopher H, Thierry C, Pierre C, et al. expression of GABA receptor-like subunits LCCH3 and GRD reveals functional diversity of Apis mellifera GABA receptors. Br J Pharmacol. 2020;177(17):3924–3940.
   PubMed Web of Science ®Google Scholar